Serum levels of adiponectin are associated with diabetic retinopathy and with adiponectin gene mutations in Caucasian patients with diabetes mellitus type 2

Experimental and Clinical Endocrinology and Diabetes

Volumn 116, Issue 9, 2008, Pages 532-536

  Zietz, B ^a   Buechler, C ^b   Kobouch, K ^b   Neumeier, M ^b   Scholmerich J ^b   Scaffler A ^b  

^a Goldberg Klinik Kelheim GmbH   (Germany)

^b UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Adipocyte; Adiponectin; Diabetes mellitus type 2; Diabetic retinopathy; Polymorphism

Indexed keywords

ADIPONECTIN; GLYCINE; HISTIDINE; TYROSINE;

AGED; ARTICLE; CAUCASIAN; COHORT ANALYSIS; DIABETIC RETINOPATHY; DNA POLYMORPHISM; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; EYE PHOTOGRAPHY; FEMALE; GENE MUTATION; GENETIC ASSOCIATION; GENOTYPE; HEALTH SURVEY; HETEROZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION; POPULATION GENETICS; PREVALENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; VITREOUS BODY;

EID: 56049121492     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1058086     Document Type: Article

References (37)

1. Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 1995: 270: 26746-26749
2. Hu E, Liang P, Spiegelman BM. AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem 1996; 271: 10697-10703
3. Maeda K, Okubo K, Shimomura I, Funahashi T, Matsuzawa Y, Matsubara K. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1. Biochem Biophys Res Commun 1996; 221: 286-289
4. Nakano Y, Tobe T, Choi-Miura NH, Mazda T, Tomita M. Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma. J Biochem 1996: 120: 803-812
5. Maeda K, Okubo K, Shimomura I, Mizuno K, Matsuzawa Y, Matsubara K. Analysis on an expression profile of genes in the human adipose tissue. Gene 1997; 190: 227-235
6. Shapiro L, Scherer PE. The crystal structure of a complement-1q family protein suggests an evolutionary link to tumor necrosis factor. Current Biology 1998; 8: 335-338
7. Okamoto Y, Arita Y, Nishida M et al. An adipocyte-derived plasma protein, adiponectin, adheres to injured vascular vessel walls. Horm Metab Res 2000; 32: 47-50
8. Ouchi N, Kihara S, Arita Y et al. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation 2000; 102: 1296-1301
9. Frystyk J, Tarnow L, Hansen TK, Parving HH, Flyvbjerg A. Increased serum adiponectin levels in type 1 diabetic patients with microvascular complications. Diabetologia 2005; 48: 1911-1918
10. Hadjadj S, Aubert R, Fumeron F et al. Increased plasma adiponectin concentrations are associated with microangiopathy in type 1 diabetic subjects. Diabetologia 2005; 48: 1088-1092
11. Schäffler A, Barth N, Palitzsch KD, Drobnik W, Schölmerich J, Schmitz G. Mutation analysis of the human adipocyte-specific apM-1 gene. Europ J Clin Invest 2000; 30: 879-887
12. Zietz B, Barth N, Spiegel D, Schmitz G, Schölmerich J, Schäffler A. Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma2 (PPARgamma2) is associated with higher levels of total cholesterol and LDL-cholesterol in male caucasian patients. Exp Clin Endocrinol Diabetes 2000; 110: 60-66
13. Kohner EM, Porta M. Protocols for screening and treatment of diabetic retinopathy in Europe. Eur J Ophthal 1991; 1: 45-54
14. SPSS Inc. SPSS for Windows 95, V. 12.0. SPSS inc. Chicago 2004
15. Bunce C, Wormald R. Leading causes of certification for blindness and partial sight in England and Wales. BMC Public Health 2006; 8:58
16. Aiello LP, Gardner TW, King GL et al. Diabetic retinopathy. Diabetes Care 1998; 21: 143-156
17. American Diabetes Association. Diabetic Retinopathy. Diabetes Care 1998; 21: 157-159
18. Sjolie AK, Stephenson J, Aldington S et al. Retinopathy and vision loss in insulin-dependent diabetes in Europe. The EURODIAB IDDM Complications Study. Ophthalmology 1997; 104: 252-260
19. Sjolie AK, Porta M, Parving HH et al. The Diabetic Retinopathy Candesartan Trials (DIRECT) Programme: baseline characteristics. J Renin Angiotensin Aldosterone Syst 2005; 6: 25-32
20. Stehouwer CDA, Schaper NC. The pathogenesis of vascular complications of diabetes mellitus: one voice or many? Europ J Clin Invest 1996; 26: 535-543
21. Sowers JR, Epstein M. Diabetes mellitus and associated hypertension, vascular disease, and nephropathy. An update. Hypertension 1995; 26: 869-879
22. Porte Jr D, Schwartz MW. Diabetes complications: Why is glucose potentially toxic? Science 1996; 272: 699-700
23. Cester N, Rabini A, Salvolini E et al. Activation of endothelial cells during insulin-dependent diabetes mellitus: a biochemical and morphological study. Europ J Clin Invest 1996; 26: 569-573
24. Kofoed-Enevoldsen A. The Steno hypothesis and glomerular basement membrane biochemistry in diabetic nephropathy. In: Mogensen, C.E. (ed.): The kidney and hypertension in diabetes 2nd edition. Boston: Kluwer 1994; 203-212
25. Williamson JR, Chang K, Frangos M et al. Hyperglycemic pseudohypoxia and diabetic complications. Diabetes 1993; 42: 801-813
26. Uhlmann K, Kovacs P, Boettcher Y, Hammes HP, Paschke R. Genetics of diabetic retinopathy. Exp Clin Endocrinol Diabetes 2006; 114: 275-294
27. Hall RW, Lang GE, Grabert M, Heinze E, Lang GK, Debatin KM. Diabetic retinopathy in pediatric patients with type-1 diabetes: effect of diabetes duration, prepubertal and pubertal onset of diabetes, and metabolic control. J Pediat 1998; 132: 760-762
28. Schalkwijk CG, Chaturvedi N, Schram MT et al. Adiponectin is inversely associated with renal function in type 1 diabetic patients. J Clin Endocrinol Metab 2006; 91:129-135
29. Yilmaz MI, Sonmez A, Acikel C et al. Adiponectin may play a part in the pathogenesis of diabetic retinopathy. Eur J Endocrinol 2004; 151: 135-140
30. Rudofsky Jr G, Schlimme M, Schlotterer A et al. No association of the 94T/G polymorphism in the adiponectin gene with diabetic complications. Diabetes Obes Metab 2005; 7: 455-459
31. Saltiel AR. You are what you secret. Nature Medicine 2001; 7: 887-888
32. Nadler ST, Attie AD. Please pass the chips: Genomic insights into obesity and diabetes. J Nutr 2001; 131: 2078-2081
33. Vidal-Puig A, O'Rahilly S. Obesity and diabetes: an avalance of new information. Mol Med Today 2000; 6: 221-223
34. Groop L. Genetics of the metabolic syndrome. British J Nutrition 2000: 83: S39-S48
35. Funahashi T, Nakamura T, Shimomura I et al. Role of adipocytokines on the pathogenesis of athersclerosis in visceral obesity. Int Medicine 1999; 38: 202-206
36. Nadler S, Stoehr JP, Schueler KL. The expression of adipogenic genes is decreased in obesity and diabetes mellitus. PNAS 2000; 97: 1371-11376
37. Zietz B, Leonhardt K, Schäffier A. Candidate genes and polymorphism analysis in type 2 diabetes mellitus. Med Klin 2006; 101: 605-616